SpIntellx harnesses the computational power of proprietary unbiased spatial analytics, spatial systems pathology, and explainable artificial intelligence (xAI) to extract information from patient primary disease pathology samples to create predictive knowledge that is required to develop personalized therapeutic strategies, identify potential novel targets for drug discovery, optimally select patient cohorts for clinical trials and improve the predictive power of prognostics/diagnostics.

Biotechnology

SpIntellx

B. Dusty Majumdar

Brian Falkenstein

Maurice Marx

Raymond Yan

A. Burak Tosun

S. Chakra Chennubhotla

Filippo Pullara

The leadership team at SpIntellx has a wealth of experience in the medical and scientific industries, with members having served as CEO of Cellomics and Cellumen, research instructors and associate professors at the University of Pittsburgh School of Medicine, and visiting researchers at the University of RomaTRE. The team is also well-educated, with degrees from universities such as the University of Michigan, SUNY Albany, and Università degli Studi di Palermo.

Leadership Team

Board of Directors

Founding Team

Leadership Team

About

Team members

Other teams at SpIntellx

Board of Directors

Founding Team